Challenges of international oncology trial collaboration—a call to action

Monica Tang, Heikki Joensuu, Robert J. Simes, Timothy J. Price, Sonia Yip, Wendy Hague, Katrin M. Sjoquist, John Zalcberg

Research output: Contribution to journalReview ArticleResearchpeer-review

4 Citations (Scopus)


International collaboration in oncology trials has the potential to enhance clinical trial activity by expediting the recruitment of large patient populations, testing treatments in diverse populations and facilitating the study of rare tumours or specific molecular subtypes. However, a number of challenges continue to hinder the efficient and productive conduct of both commercial and non-commercial international clinical trials. These challenges include complex and burdensome regulatory requirements, the high cost of conducting trials, and logistical challenges associated with ethics review, drug supply and biospecimen collection and management. We propose solutions to promote oncology trial collaboration, such as regulatory reform, harmonisation of trial initiation and management processes and greater recognition and funding of academic (non-commercial) clinical trials. It is only through coordinated effort and leadership from researchers, regulators and those responsible for health systems that the full potential of international trial collaboration can be realised.

Original languageEnglish
Pages (from-to)515-521
Number of pages7
JournalBritish Journal of Cancer
Issue number7
Publication statusPublished - 1 Oct 2019

Cite this